Mutational spectrum and genotype-phenotype correlation in Mexican patients with infantile-onset and late-onset Pompe disease

被引:0
|
作者
Martinez-Montoya, Valentina [1 ,2 ]
Sanchez-Sanchez, Luz Maria [3 ]
Sandoval-Pacheco, Roberto [4 ]
Castro, Diana Monica Anaya [5 ]
Arellano-Valdez, Carmen Araceli [6 ]
Avila-Rejon, Carmen Amor [7 ]
Aguilar-Juarez, Pedro Alejandro [8 ]
Espino-Pluma, Martin [9 ]
Gonzalez-Santillanes, Cruz Antonio [10 ]
Martinez-Segovia, Rosa Isela [11 ]
Olmos-Morfin, Dorian [12 ]
la Torre, Ofelia Padilla-De [13 ]
Solis-Sanchez, Ishar [14 ]
Espinosa, Monica Vazquez-Del Mercado [15 ]
Villarroel-Cortes, Camilo Ernesto [16 ]
Velarde-Felix, Jesus Salvador [17 ]
Lopez-Valdez, Jaime [18 ]
Olaiz-Urbina, Julio [19 ]
Ricardez-Marcial, Edgar [20 ]
Vergara-Sanchez, Imelda [21 ]
Radillo-Diaz, Pablo [22 ]
Kazakova, Ekaterina [22 ]
De la Fuente-Cortez, Beatriz [23 ]
del Carmen Marquez-Quiroz, Luz [24 ,25 ]
Torres-Octavo, Benjamin [26 ]
Diaz-Martinez, Rubicel [27 ]
机构
[1] Inst Oftalmol Conde ABC Santa Fe, Prolongacion Vasco de Quiroga 4001,Torre A,4to pis, Mexico City 0537, Mexico
[2] Inst Med Vis, Genet Serv, Mexico City, Mexico
[3] Inst Mexicano Seguro Social IMSS, Hosp Especial UMAE 25, Pediat Serv, Monterrey, Nuevo Leon, Mexico
[4] Hosp Cent Mil Secretaria Def Nacl, Pediat Emergency Serv, Mexico City, Mexico
[5] Hosp Gen Dr Ernesto Ramos Bours, Neurol Serv, Secretaria Salud Publ, Hermosillo, Sonora, Mexico
[6] IMSS, Ctr Med Nacl Occidente, Pediat Internal Med & Rheumatol Serv, High Specialty Med Unit,Hosp Pediat, Guadalajara, Jalisco, Mexico
[7] Hosp Alta Especial Veracruz, Genet Dept, Serv Salud Veracruz, Xalapa, Veracruz, Mexico
[8] Ctr Med Nacl 20 Noviembre, Neurol Serv, Inst Segur & Serv Sociales Trabajadores Estado ISS, Mexico City, Mexico
[9] IMSS, Internal Med Serv, Clin Enfermedades Lisosomales, Hosp Gen Zona 1,Tlaxcala Xicohtencatl, Tlaxcala, Mexico
[10] IMSS, Hosp Gen Reg 1, Rehabil Serv, Culiacan, Sinaloa, Mexico
[11] Inst Mexicano Seguro Social IMSS, Hosp Especial UMAE 25, Internal Med Serv, Monterrey, Nuevo Leon, Mexico
[12] Ctr RehabilInfantil Teleton, Morelia, Michoacan, Mexico
[13] IMSS, Ctr Med Nacl Occidente, Neurol Serv, Guadalajara, Jalisco, Mexico
[14] Hosp Espanol Veracruz, Ctr Neurol, Clin Enfermedades Neuromusculares, Veracruz, Veracruz, Mexico
[15] Hosp Civil Dr Juan I Menchaca, Rheumatol Serv, Hosp Civil Dr, Guadalajara, Jalisco, Mexico
[16] Inst Nacl Pediat, Genet Serv, Mexico City, Mexico
[17] Univ Autonoma Sinaloa, Culiacan, Sinaloa, Mexico
[18] Centenario Hosp Miguel Hidalgo, Genet Serv, Secretaria Salud, Aguascalientes, Aguascalientes, Mexico
[19] IMSS, Pediat Serv, Hosp Gen Zona 1, La Paz, Baja California, Mexico
[20] IMSS, Ctr Med Nacl Raza, Genet Serv, Mexico City, Mexico
[21] IMSS, Pediat Neurol Serv, Unidad Med Alta Especial, Merida, Yucatan, Mexico
[22] Sanofi Genzyme, Med Dept Rare Dis, Mexico City, Mexico
[23] Univ Autonoma Nuevo Leon, Hosp Univ, Genet Serv, Monterrey, Nuevo Leon, Mexico
[24] Genos Med, Mexico City, Mexico
[25] Univ Nacl Autonoma Mexico, Mexico City, Mexico
[26] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Fibra Nerviosa Delgada, Mexico City, Mexico
[27] Hosp Reg Alta Especial Nino, Genet Serv, Secretaria Salud, Villahermosa, Tabasco, Mexico
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 07期
关键词
acid alpha-glucosidase; GAA gene; metabolic myopathy; phenotype-genotype correlation; Pompe disease; pseudodeficiency allele; rare disease; LYSOSOMAL STORAGE DISORDERS; GAA GENE; SCREENING-PROGRAM; GUIDELINES; VARIANTS;
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pompe Disease (PD) is a metabolic myopathy caused by variants in the GAA gene, resulting in deficient enzymatic activity. We aimed to characterize the clinical features and related genetic variants in a series of Mexican patients. Methods: We performed a retrospective study of clinical records of patients diagnosed with LOPD, IOPD or pseudodeficiency. Results: Twenty-nine patients were included in the study, comprising these three forms. Overall, age of symptom onset was 0.1 to 43 years old. The most frequent variant identified was c.-32-13T>G, which was detected in 14 alleles. Among the 23 different variants identified in the GAA gene, 14 were classified as pathogenic, 5 were likely pathogenic, and 1 was a variant of uncertain significance. Two variants were inherited in cis arrangement and 2 were pseudodeficiency-related benign alleles. We identified two novel variants (c.1615 G>A and c.1076-20_1076-4delAAGTCGGCGTTGGCCTG). Conclusion: To the best of our knowledge, this series represent the largest phenotypic and genotypic characterization of patients with PD in Mexico. Patients within our series exhibited a combination of LOPD and IOPD associated variants, which may be related to genetic diversity within Mexican population. Further population-wide studies are required to better characterize the incidence of this disease in Mexican population.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Consensus treatment recommendations for late-onset Pompe disease
    Cupler, Edward J.
    Berger, Kenneth I.
    Leshner, Robert T.
    Wolfe, Gil I.
    Han, Jay J.
    Barohn, Richard J.
    Kissel, John T.
    MUSCLE & NERVE, 2012, 45 (03) : 319 - 333
  • [32] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    V. Gragnaniello
    S. Fecarotta
    A. Pecoraro
    A. Tarallo
    A. Catzola
    G. Spadaro
    G. Parenti
    R. Della Casa
    Neurological Sciences, 2019, 40 : 1453 - 1455
  • [33] Challenges in diagnosis and treatment of late-onset Pompe disease
    Desnuelle, Claude
    Salviati, Leonardo
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (05) : 443 - 448
  • [34] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    Gragnaniello, V.
    Fecarotta, S.
    Pecoraro, A.
    Tarallo, A.
    Catzola, A.
    Spadaro, G.
    Parenti, G.
    Della Casa, R.
    NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
  • [35] Infantile-onset Pompe disease with neonatal debut: A case report and literature review
    Martinez, Miriam
    Garcia Romero, Mar
    Garcia Guereta, Luis
    Cabrera, Marta
    Regojo, Rita M.
    Albajara, Luis
    Couce, Maria L.
    Saenz de Pipaon, Miguel
    MEDICINE, 2017, 96 (51)
  • [36] Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology
    Goina, Elisa
    Peruzzo, Paolo
    Bembi, Bruno
    Dardis, Andrea
    Buratti, Emanuele
    MOLECULAR THERAPY, 2017, 25 (09) : 2117 - 2128
  • [37] Analysis of voice quality in patients with late-onset Pompe disease
    Szklanny, Krzysztof
    Gubrynowicz, Ryszard
    Iwanicka-Pronicka, Katarzyna
    Tylki-Szymanska, Anna
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [38] Late-onset Pompe Disease: A Diagnostic Challenge
    Shah, Ritesh
    Balasubramaniam, Seema
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2021, 10 (02) : 146 - 149
  • [39] Analysis of voice quality in patients with late-onset Pompe disease
    Krzysztof Szklanny
    Ryszard Gubrynowicz
    Katarzyna Iwanicka-Pronicka
    Anna Tylki-Szymańska
    Orphanet Journal of Rare Diseases, 11
  • [40] Screening for late-onset Pompe disease in Poland
    Jastrzebska, Aleksandra
    Potulska-Chromik, Anna
    Lusakowska, Anna
    Jastrzebski, Miosz
    Lipowska, Marta
    Kierdaszuk, Biruta
    Kaminska, Anna
    Kostera-Pruszczyk, Anna
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 140 (04): : 239 - 243